NCT05344482View on ClinicalTrials.gov

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

CompletedOBSERVATIONAL
Enrollment

277

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Plaque Psoriasis
Interventions
OTHER

Secukinumab

Included all the patients treated with secukinumab

Trial Locations (1)

07936-1080

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY